Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada flag Canada · Delayed Price · Currency is CAD
0.1050
0.00 (0.00%)
Jul 21, 2026, 2:57 PM EST

Rapid Dose Therapeutics Revenue

In the fiscal year ending February 28, 2026, Rapid Dose Therapeutics had annual revenue of 2.77M CAD with 33.00% growth. Rapid Dose Therapeutics had revenue of 660.52K in the quarter ending February 28, 2026, a decrease of -1.21%.

Revenue
2.77M
Revenue Growth
+33.00%
P/S Ratio
5.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 20262.77M688.14K33.00%
Feb 28, 20252.09M1.06M104.34%
Feb 29, 20241.02M302.13K42.06%
Feb 28, 2023718.30K-1.03M-59.00%
Feb 28, 20221.75M996.72K131.98%
Feb 28, 2021 Pro Pro Pro
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition